Tissue Regenix Group plc (TRX) ORD GBP0.001

Sell:32.00pBuy:34.00pNo change

Prices delayed by at least 15 minutes
Sell:32.00p
Buy:34.00p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:32.00p
Buy:34.00p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Tissue Regenix Group plc is a medical device company in regenerative medicine. The principal activity of the Company is the exploitation of platform technologies in the field of bone graft substitutes and soft tissue. It is focused on the development of regenerative products utilizing its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing sterile bone allografts. Its divisions include dCELL, BioRinse and GBM-V. The Company's patented decellularization technology (dCELL) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient's body that can be used to repair diseased or damaged body structures. Its proprietary BioRinse technology platform is primarily utilized to provide sterile tissue prepared in a manner to minimize the negative effects of processing. GBM-V produces tissue preparations for ophthalmology, primarily cornea, using conventional, classical methods.

Key people

Daniel R. Lee
Chief Executive Officer, Executive Director
Brandon Largent
Interim Chief Financial Officer
Tina Trimble
Senior Vice President of Donor Services, US
Patti Gary
Vice President - Clinical Affairs
Lance Johnson
Vice President of Quality and Regulatory, US
Gerald Sharpe
Vice President - Strategic Partnerships
Christine Rowley
Technical and Operations Director, UK
Kirsten Lund
EMEA Business Director, Company Secretary
Jonathan Martin Glenn
Non-Executive Chairman of the Board
Shervanthi Homer-Vanniasinkam
Non-Executive Independent Director
Brian Phillips
Non-Executive Independent Director
Trevor Michael Phillips
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    TRX
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    GB00BNTXR104
  • Market cap
    £23.51m
  • Employees
    86
  • Shares in issue
    71.40m
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.